QCI Interpret for Oncology

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors

52 views
July 18, 2024
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes, targeted NGS is not only a cost-effective solution, but can rapidly deliver insights into a tumor molecular profile.

To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.

In this webinar, attendees will:
- Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
- Learn about the design and application of these NGS panels
- Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput


Category: QCI Interpret for Oncology, Sample to Insight

Related videos

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

388 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...

QCI Interpret for Oncology

Comprehensive Molecular Tumor Analysis with Alacris Theranostics

301 views March 09, 2023

Precision oncology approaches have made great strides harnessing individual...

QCI Interpret for Oncology

Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...

285 views October 31, 2023

Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...

QCI Interpret for Oncology

Comparison of methods in routine somatic diagnostics

271 views April 12, 2022

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular...